Consultant

Dr Arti Mahto

Consultant Rheumatologist
Bsc MBBCh (Distinction) MRCP (Rheum) PhD
Profile Photo for Arti Mahto

Dr. Mahto is a London-trained Rheumatologist with interests in early inflammatory arthritis, biologic treatment and MSK Ultrasound. She completed her PhD in the field of rheumatoid arthritis, exploring treatment stratification approaches to disease. She is also qualified in internal medicine, providing an integrated approach to multi-system disease.

Rheumatology
Hindi, Punjabi, Urdu
In-person
From £250

Bio

Dr Arti Mahto is currently a consultant Rheumatologist at Kings College Hospital where she provides early assessment and treatment of inflammatory arthritis and is the adolescent rheumatology lead. Her experience and use of musculoskeletal ultrasound allow her to accurately diagnose inflammatory conditions and fibromyalgia. 

She has also led a dedicated fibromyalgia project at Whipps Cross Hospital in conjunction with pain specialists, physiotherapy and psychology and more recently has been involved in long COVID clinics at King's College Hospital.

She is personable and friendly and has a keen interest in teaching and has also been involved in patient groups locally. She speaks Urdu, Hindi and Punjabi. ​

Dr Arti Mahto trained at Cardiff University and completed her specialist training across several prestigious hospitals around North and East London. She was awarded her PhD by Queen Mary’s University and Barts London exploring the role of B-cells within the synovium and response to rituximab therapy. 

She has presented her work at international conferences and has a number of publications focusing on the role of the synovium in rheumatoid arthritis.

More information

  • Consultant Rheumatologist
    Kings College Hospital

  • Early inflammatory arthritis including rheumatoid and psoriatic arthritis
  • Musculoskeletal ultrasound and guided joint injections

  • Year qualified 2007
  • Cardiff University

Dr. Arti Mahto has particular expertise in musculoskeletal ultrasound and incorporates this routinely into her practice, enhancing both diagnosis and treatment.

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Year: 2021

Published by: Lancet

Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation Requirements

Authors: Frances Humby, Stephen Kelly, Serena Bugatti, Antonio Manzo, Andrew Filer, Arti Mahto, Joao Eurico Fonseca, Bernard Lauwerys, Maria-Antonietta D'Agostino, Esperanza Naredo, Rik Lories, Carlomaurizio Montecucco, Paul Peter Tak, Oliver Fitzgerald

Year: 2016

Published by: Journal of Rheumatology

A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis PatientsAuthors: Alessandra Nerviani, Maria Di Cicco, Arti Mahto, Gloria Lliso-Ribera, Felice Rivellese, Georgina Thorborn, Rebecca Hands, Mattia Bellan, Daniele Mauro, Marie-Astrid Boutet, Giovanni Giorli, Myles Lewis, Stephen Kelly, Michele Bombardieri, Frances Humby

Year: 2020

Published by: Frontiers in Immunology

Share

Contact us

Request an appointment with our world-leading consultants today, or speak to our helpful advisors for tailored advice.